Start for free
Start for free
NFX Bio logo

NFX Bio

North America, California, United States, San Francisco

Description

NFX Bio is a fund initiative that seeks to invest in scientist-founders at the seed stage with a technology platform approach.

Investor Profile

NFX Bio has made 8 investments, with 1 in the past 12 months and 38% as lead.

Stage Focus

  • Seed (88%)
  • Series B (13%)

Country Focus

  • United States (63%)
  • Israel (38%)

Industry Focus

  • Therapeutics
  • Biotechnology
  • Medical
  • Health Care
  • Genetics
  • Health Diagnostics
  • Education
  • Hardware
  • Pet
  • Software
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does NFX Bio frequently co-invest with?

KdT Ventures
KdT Ventures
North America, Texas, United States, Austin
Co-Investments: 1
Pear VC
Pear VC
North America, California, United States, Menlo Park
Co-Investments: 1
B
BEVC
North America, California, United States, Berkeley
Co-Investments: 1
Pioneer Fund
Pioneer Fund
North America, California, United States, San Francisco
Co-Investments: 2
BV
Biovision Ventures
Europe, Luxembourg, Belgium, Luxembourg
Co-Investments: 1
Asymmetry Ventures
Asymmetry Ventures
North America, California, United States, San Francisco
Co-Investments: 1
Brightstone Venture Capital
Brightstone Venture Capital
North America, Minnesota, United States, Minneapolis
Co-Investments: 1
Alumni Ventures
Alumni Ventures
North America, New Hampshire, United States, Manchester
Co-Investments: 1
A
AAVCF3
North America, California, United States, San Francisco
Co-Investments: 1
Eli Lilly
Eli Lilly
North America, Indiana, United States, Indianapolis
Co-Investments: 1

Which angels does NFX Bio often collaborate with?

MZ
Mei Z.
North America, United States
Shared Deals: 1

What are some of recent deals done by NFX Bio?

Radar Therapeutics

Berkeley, California, United States

Radar Therapeutics pioneer in treatment modality, precision-expressed mRNA-based therapeutics.

MedicalTherapeutics
SeedMay 23, 2024
Amount Raised: $13,400,000
Eleven Therapeutics

Tel Aviv, Tel Aviv, Israel

Eleven Therapeutics is a research firm that uses the power of RNAi technology to help create therapeutics.

BiotechnologyMedicalProduct ResearchTherapeutics
SeedAug 2, 2022
Amount Raised: $22,000,000
EdiTy Therapeutics

Rehovot, HaMerkaz, Israel

EdiTy Therapeutics is a biotechnology company that develops a gene-editing technology designed for in-vivo gene-editing of target cells.

BiotechnologyGeneticsMedical DeviceTherapeutics
SeedJul 12, 2022
resistanceBio

Menlo Park, California, United States

Solving cancer resistance.

BiotechnologyHealth Care
SeedJul 4, 2022
Amount Raised: $12,000,000
La Jolla Labs

La Jolla, California, United States

La Jolla Labs is a therapeutics company that delivers high-throughput screening technology for drug discovery.

BiotechnologyLife ScienceTherapeutics
SeedJan 1, 2022
Pangea Therapeutics Ltd.

Tel Aviv, Tel Aviv, Israel

Pangea Therapeutics Ltd. is a pharma/biotech company based on its proprietary platform.

BiotechnologyPharmaceuticalTherapeutics
SeedJul 7, 2021
Amount Raised: $7,000,000
C2i Genomics

New York, New York, United States

C2i Genomics provides cloud-based cancer diagnostic services to pharmaceutical and diagnostic organizations.

GeneticsHealth CareHealth DiagnosticsTherapeutics
Series BApr 15, 2021
Amount Raised: $100,000,000
CleverPet

San Diego, California, United States

CleverPet is a hardware and software company that offers smart light and sound games for dogs.

EducationHardwarePetSoftware
SeedJun 5, 2015
Amount Raised: $120,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator